NASHVILLE, Tenn., Sept. 4, 2019 /PRNewswire/ -- Today Tivity Health® (Nasdaq: TVTY) announced the results of a

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Global marketing and communications firm, FINN Partners, has acquired Lazar Partners, a 22-person, health-dedica

CHICAGO, Sept. 4, 2019 /PRNewswire/ -- Many individuals struggling with self-harm often find themselves stuck in a cycle. The cycle impairs how they function in daily life and can become an addiction.

SEATTLE, Sept. 4, 2019 /PRNewswire/ -- Vera Whole Health, a national leader in advanced primary care, today released an eBook to provide employers, insurers, and health syste

CAMBRIDGE, Mass., Sept. 4, 2019 /PRNewswire/ -- Count Me In, a non-profit research initiative, has launched the Brain Cancer Project (BrainCancerProject.org), a patient-partner

TORONTO, Sept. 4, 2019 /PRNewswire/ - Catalyst, the global nonprofit focused on accelerating progress for women at work, announced today that Susan Bartlett, Chief Executive Officer of the award-winning service design consultancy

BROKEN ARROW, Okla., Sept. 4, 2019 /PRNewswire/ -- A new study, released today by Broken Arrow Public Schools and CloroxPro, has shown the positive impact of daily disinfection in a school environment by using the Clorox® Total 360® System. After implementing the system daily throughout the 2018-19 schoo

CARLSBAD, Calif., Sept. 4, 2019 /PRNewswire/ -- Prescient Metabiomics, a privately held company and a subsidiary of Prescient Medicine Holdings, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted the company's submission for Breakthrough Device designation to its LifeKit® Prevent Colorectal Neoplasia Test. This Breakthro

RADNOR, Pa., Sept. 4, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that Michael Stubblefield, President and Chief Executive Officer, and Tom

BETHESDA, Md., Sept. 4, 2019 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has expanded its senior management team with the addition of Dr. Kevin T. Duffy as Vice President, Medical Affairs and E